The GI-MAP (Gastrointestinal Microbial Assay Plus) is a comprehensive stool test designed to assess the status of the gastrointestinal (GI) tract. This test is often used by healthcare professionals to gather detailed information about the microbiome, which refers to the community of microorganisms living in the digestive system.

Key features and benefits of the GI-MAP may include:

​

1. Microbial Diversity Assessment:

   • The GI-MAP provides information about the diversity and abundance of various microorganisms in the gut, including bacteria, viruses, parasites, and fungi.

2. Pathogen Detection:

   • The test is designed to identify and quantify potential pathogens such as bacteria, parasites, and viruses that may be present in the GI tract. This can help in diagnosing infections or imbalances.

3. Commensal Bacteria Analysis:

   • Commensal bacteria are the beneficial microorganisms that play a crucial role in maintaining gut health. The GI-MAP assesses the levels of these beneficial bacteria to evaluate the overall balance of the microbiome.

4. Inflammatory Markers:

   • The test may include markers that indicate the presence of inflammation in the GI tract. Elevated levels of these markers can suggest conditions such as inflammatory bowel disease (IBD) or other inflammatory conditions.

5. Digestive Function:

   • Some versions of the GI-MAP may include markers related to digestive function, such as the measurement of pancreatic elastase, which assesses pancreatic enzyme activity.

6. Antibiotic Resistance Genes:

   • The test may identify the presence of antibiotic resistance genes in the gut microbiome. This information can be valuable for healthcare providers when considering antibiotic treatment.

7. Clinical Insights:

   • By providing a comprehensive analysis of the gut microbiome, the GI-MAP can offer valuable insights into the underlying causes of various gastrointestinal symptoms or conditions, helping healthcare professionals tailor treatment plans.

8. Personalized Treatment Plans:

   • Based on the results of the GI-MAP, healthcare providers may develop personalized treatment plans that target specific imbalances or issues identified in the gut microbiome.